Literature DB >> 9645272

Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine.

M Singh1, S K Das, S Suri, O Singh, G P Talwar.   

Abstract

PROBLEM: Phase II clinical trials with the heterospecies dimer of beta hCG and alpha-subunit of ovine luteinizing hormone (HSD)-human chorionic gonadotrophin (hCG) vaccine showed that pregnancy was prevented at and above 50 ng/ml titers, whereas conceptions occurred below 35 ng/ml of hCG bioneutralization capacity. The effect of below-protective threshold anti-hCG antibodies on the progression of pregnancy and the normality of progeny was studied. METHOD OF STUDY: Four women enrolled by informed consent in the Phase II trials. The women studied were immunized with the HCG vaccine and did not receive booster injections in consideration of their desire to have another child. They were examined clinically at least once every month until delivery. The babies were followed up from 2 to 3.5 years, and their anthropometric indices were compared with elder siblings.
RESULTS: The pregnancies progressed to 35 to 38 weeks with the usual obstetric problems, and the children developed normally.
CONCLUSIONS: The anti-fertility effect of the HSD-hCG vaccine is reversible and low titers of antibodies below the protective threshold have no apparent side effects on the progression of pregnancy and on the early development of the progeny.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645272     DOI: 10.1111/j.1600-0897.1998.tb00376.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

1.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

2.  New dimensions in vaccinology: A new insight.

Authors:  D Tomar; V Chattree; V Tripathi; A A Khan; A R Bakshi; D N Rao
Journal:  Indian J Clin Biochem       Date:  2005-01

Review 3.  Contraceptive vaccines targeting factors involved in establishment of pregnancy.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2011-04-11       Impact factor: 3.886

4.  A shot at contraception: In India, a nonagenarian renews testing of a birth control vaccine.

Authors:  Killugudi Jayaraman
Journal:  Nat Med       Date:  2018-02-07       Impact factor: 53.440

5.  Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.

Authors:  Madelon Q Wentink; Tilman M Hackeng; Sebastien P Tabruyn; Wouter C Puijk; Klaus Schwamborn; Daniele Altschuh; Rob H Meloen; Teun Schuurman; Arjan W Griffioen; Peter Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

6.  Infertility in mice induced by the rhesus monkey chorionic gonadotropin beta-subunit glycoprotein (rmCGbeta) using DNA immunization.

Authors:  Yun Chen; Zhe Liu; Ying Yang; You-Zhen Chen; Jing-Pian Peng
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

Review 7.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 8.  Vaccines for immunological control of fertility.

Authors:  Satish K Gupta; Pankaj Bansal
Journal:  Reprod Med Biol       Date:  2009-12-01

9.  Vaccines: past, present and future.

Authors:  Stanley A Plotkin
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.